Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944]
Delong Chen , Zhen Ye , Chao Wang , Qingqing Wang , Haibin Wang , Vincent Kuek , Ziyi Wang , Heng Qiu , Jinbo Yuan , Jacob Kenny , Fan Yang , Jianbo He , Yun Liu , Gang Wang , Meng Zhang , Gangyu Zhang , Junjian Wang , Peng Chen , Jiake Xu
{"title":"Corrigendum to “Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation” [Pharmacol. Res. 159 (2020) 104944]","authors":"Delong Chen , Zhen Ye , Chao Wang , Qingqing Wang , Haibin Wang , Vincent Kuek , Ziyi Wang , Heng Qiu , Jinbo Yuan , Jacob Kenny , Fan Yang , Jianbo He , Yun Liu , Gang Wang , Meng Zhang , Gangyu Zhang , Junjian Wang , Peng Chen , Jiake Xu","doi":"10.1016/j.phrs.2024.107463","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19918,"journal":{"name":"Pharmacological research","volume":"209 ","pages":"Article 107463"},"PeriodicalIF":9.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043661824004080","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944] 的更正。
期刊介绍:
Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.